Profile data is unavailable for this security.
About the company
Bio Vitos Pharma AB, formerly Hemcheck Sweden AB, is a Sweden-based medical technology company. The Company produces and commercializes a service for near-patient detection of hemolysis in blood samples. The concept consists of disposable tests as well as readers that can quickly, directly upon sampling, identify hemolysed blood samples in vacuum tubes and blood gas syringes. The Company's, ruptured red blood cells, is a common reason globally why blood samples cannot be analyzed accurately and is also a biomarker for acute medical conditions. Its goal is to contribute to improved healthcare by offering user-friendly solutions for the detection of hemolysed blood samples in direct connection with blood sampling near the patient. By doing so, the Company can contribute to increased patient safety, more efficient processes and lower costs.
- Revenue in SEK (TTM)1.11m
- Net income in SEK-14.84m
- Incorporated2010
- Employees1.00
- LocationBio Vitos Pharma ABNanna Svartz vag 4SOLNA 171 65SwedenSWE
- Phone+46 542022211
- Websitehttps://hemcheck.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Invent Medic Sweden AB | 6.73m | -8.04m | 26.88m | 9.00 | -- | 5.51 | -- | 3.99 | -0.1939 | -0.1939 | 0.1613 | 0.0566 | 0.6084 | 2.31 | 4.34 | 841,046.30 | -72.67 | -97.56 | -133.97 | -121.06 | 77.43 | 77.16 | -119.45 | -490.98 | 0.3951 | -12.43 | 0.2703 | -- | 115.97 | 177.53 | 28.77 | -- | -22.61 | -- |
| Miris Holding AB (publ) | 17.32m | -9.41m | 29.56m | 10.00 | -- | 3.81 | -- | 1.71 | -0.2092 | -0.2092 | 0.3641 | 0.0271 | 0.824 | 0.1117 | 7.25 | 1,732,100.00 | -44.74 | -59.61 | -95.35 | -111.08 | 97.83 | 86.68 | -54.30 | -103.61 | 0.7091 | -8.08 | 0.0903 | -- | -17.19 | 2.53 | -20.86 | -- | -- | -- |
| Inhalation Sciences Sweden AB | 15.48m | -3.93m | 39.13m | 8.00 | -- | 3.48 | -- | 2.53 | -0.2796 | -0.2796 | 1.09 | 0.7409 | 0.8096 | 0.6328 | 4.37 | 1,935,000.00 | -20.53 | -27.93 | -29.23 | -43.82 | 86.29 | 71.13 | -25.36 | -48.02 | 2.81 | -6.49 | 0.0639 | -- | 43.55 | 26.33 | 60.87 | -- | -- | -- |
| Scandinavian Real Heart AB | 0.00 | -75.02m | 46.12m | 12.00 | -- | 0.504 | -- | -- | -0.5182 | -0.5182 | 0.00 | 0.4425 | 0.00 | -- | -- | 0.00 | -73.46 | -24.27 | -87.03 | -26.81 | -- | 832.41 | -- | -6,070.11 | -- | -700.38 | 0.1023 | -- | -100.00 | -- | -385.97 | -- | -25.76 | -- |
| Scandinavian ChemoTech AB | 4.61m | -16.98m | 47.29m | 6.00 | -- | 11.97 | -- | 10.25 | -1.04 | -1.04 | 0.2749 | 0.1821 | 0.2583 | 0.518 | 1.17 | 768,833.30 | -95.08 | -87.29 | -95.08 | -118.55 | 32.45 | 252.05 | -368.11 | -2,122.77 | -- | -14.56 | 0.00 | -- | 496.62 | 19.13 | 7.28 | -- | -- | -- |
| ProstaLund AB | 17.57m | -21.64m | 49.22m | 6.00 | -- | 0.7072 | -- | 2.80 | -0.2752 | -0.2752 | 0.2226 | 0.5656 | 0.2627 | 0.3308 | 12.78 | -- | -32.35 | -29.14 | -39.54 | -35.01 | 72.73 | 75.26 | -123.16 | -68.94 | 0.7618 | -155.80 | 0.1065 | -- | 27.54 | 10.36 | -53.27 | -- | 20.35 | -- |
| Bio Vitos Pharma AB | 1.11m | -14.84m | 50.83m | 1.00 | -- | 1.43 | -- | 45.84 | -0.1498 | -0.1498 | 0.006 | 0.0905 | 0.0457 | 0.092 | 3.02 | 1,108,910.00 | -61.08 | -31.11 | -62.90 | -32.92 | 90.59 | -- | -1,338.03 | -1,026.76 | 5.84 | -- | 0.00 | -- | 126.97 | -- | 13.64 | -- | -- | -- |
| iZafe Group AB | 4.77m | -31.86m | 60.50m | 8.00 | -- | 2.94 | -- | 12.69 | -0.1332 | -0.1332 | 0.0202 | 0.0747 | 0.1111 | 2.67 | 3.41 | 681,285.70 | -74.23 | -52.17 | -85.90 | -69.40 | -167.81 | -198.20 | -668.02 | -487.50 | 0.6358 | -- | 0.1085 | -- | 149.93 | -24.79 | -36.76 | -- | -41.66 | -- |
| Holder | Shares | % Held |
|---|---|---|
| FCG Fonder ABas of 30 Aug 2024 | 55.70k | 0.02% |
